MD Anderson and EMD Serono enter 3-year strategic collaboration to accelerate development of investigational oncology/immuno-oncology compounds
HOUSTON - The University of Texas MD Anderson Cancer Center and EMD Serono, the healthcare business of Merck KGaA, Darmstadt, ...




